Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy
- Sponsor
- Zhejiang University
- Study ID
- NCT06423274
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- fundus photography — DIAGNOSTIC_TESTusing artificial intelligence to identify diabetic retinopathy using fundus photography
- optical coherence tomography — DIAGNOSTIC_TESTdetect diabetic retinopathy and diabetic macular edema by optical coherence tomography
- fundus fluorescence angiography — DIAGNOSTIC_TESTdetect diabetic retinopathy by fundus fluorescence angiography
Study Details
This study plans to compare the accuracy of artificial intelligence (AI)-assisted fundus images with other ophthalmic devices such as optical coherence tomography (OCT) and fundus fluorescence angiography (FFA) in the diagnosis of diabetic retinopathy and diabetic macular edema.
Key Dates
- First listed
- May 21, 2024
- Start date
- Jul 10, 2024
- Status verified
- Jul 2024
- Primary completion
- Sep 1, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: artificial intelligence-assisted fundus photographyArtificial intelligence-assisted fundus photography in patients with diabetic retinopathy
- Arm: optical coherence tomographyoptical coherence tomography in patients with diabetic retinopathy
- Arm: fundus fluorescence angiographyfundus fluorescence angiography in patients with diabetic retinopathy
Primary Outcome Measure
The accuracy [ Time Frame: Baseline-Month 12 ]
Central Contacts
- Hongkang Wu, MMS+8618969978676
Find similar trials
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic RetinopathyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama